🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Chronic kidney disease (CKD), is characterized by accelerated development o...
Status
Completed
Location
Poznan University of Medical Sciences
Start Date
2016-03-25
Trial ID
NCT05214872
Treatments Being Tested
This is a Phase 1/2 study of HST-1011, a CBL-B inhibitor, being developed f...
Status
Active Not Recruiting
Location
Florida Cancer Specialists
Start Date
2023-03-15
Trial ID
NCT05662397
Treatments Being Tested
This study will evaluate efficacy and safety of anti-PD-1/PD-L1 antibodies ...
Status
Recruiting
Location
EuroCityClinic LLC
Start Date
2025-08-14
Trial ID
NCT07130032
Treatments Being Tested
This is a multicenter, open-label, single-arm, prospective clinical study o...
Status
Recruiting
Location
The First Affiliated Hospital with Nanjing Medical University
Start Date
2026-02-07
Trial ID
NCT07410520
Treatments Being Tested
This multicenter retrospective study evaluated the efficacy and safety of s...
Status
Completed
Location
The Second Affiliated Hospital of Guangzhou Medical University
Start Date
2022-06-01
Trial ID
NCT06916546
A first-in-human, Phase 1, open-label, multicenter study of WTX-330 adminis...
Status
Completed
Location
HonorHealth
Start Date
2022-12-06
Trial ID
NCT05678998
Treatments Being Tested
The study will evaluate the clinical activity of PD-(L)1 Checkpoint Inhibit...
Status
Terminated
Location
The University of Arizona Cancer Center
Start Date
2018-09-11
Trial ID
NCT03606174
Treatments Being Tested
A study to investigate efficacy and safety of ceralasertib plus durvalumab ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2023-06-21
Trial ID
NCT05941897
Treatments Being Tested
The goal of this study is to understand whether CRB-701, a targeted form of...
Status
Not Yet Recruiting
Location
The University of Arizona Cancer Center
Start Date
2026-09-20
Trial ID
NCT07768189
Treatments Being Tested
CONTESSA TRIO is a multi-cohort, multicenter, Phase 2 study of tesetaxel, a...
Status
Terminated
Location
Sarah Cannon Research Institute - Florida Cancer Specialists
Start Date
2019-07-09
Trial ID
NCT03952325
Treatments Being Tested